Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.700
-0.010 (-0.58%)
May 20, 2026, 9:33 AM EDT - Market open
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.76 million as of May 20, 2026. Its market cap has decreased by -32.73% in one year.
Market Cap
1.76M
Enterprise Value
-1.82M
1-Year Change
-32.73%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.42M to $1.76M, a decrease of -97.39%. That is a compound annual growth rate of -55.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 1.77M | 46.18% |
| Dec 31, 2025 | 1.21M | -55.01% |
| Dec 31, 2024 | 2.69M | 78.09% |
| Dec 29, 2023 | 1.51M | -80.24% |
| Dec 30, 2022 | 7.65M | -84.67% |
| Dec 31, 2021 | 49.89M | -26.00% |
| Nov 10, 2021 | 67.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nexalin Technology | 6.61M |
| HeartSciences | 5.99M |
| Beyond Air | 5.69M |
| iTonic Holdings | 5.02M |
| Autonomix Medical | 3.24M |
| Aethlon Medical | 3.22M |
| Nuwellis | 2.58M |
| INVO Fertility | 2.31M |